Safety and Tolerability of the Dual 5-Alpha Reductase Inhibitor Dutasteride in the Treatment of Androgenetic Alopecia

    January 2016 in “ Annals of Dermatology ”
    Gwang Seong Choi, Joon Bum Kim, Shin J. Oh … Won Young Lee
    Studysummary This study found that dutasteride 0.5 mg was generally well-tolerated and led to overall improvement in male patients aged 18 to 41 with androgenic alopecia in a Korean clinical practice setting.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on anndermatol.org →
    Discuss this study in the Community →

    Research cited in this study 13

    1. A Randomized, Active- and Placebo-Controlled Study of the Efficacy and Safety of Different Doses of Dutasteride Versus Placebo and Finasteride in the Treatment of Male Subjects with Androgenetic Alopecia Journal of The American Academy of Dermatology · 2014
    2. Organic Causes of Erectile Dysfunction in Men Under 40 Urologia Internationalis · 2013
    3. The Annual Changes of Clinical Manifestation of Androgenetic Alopecia Clinic in Korean Males and Females: An Outpatient-Based Study Annals of Dermatology · 2013
    4. Hair Characteristics and Androgenetic Alopecia in Koreans Journal of The Korean Medical Association · 2013
    5. Efficacy, Safety, and Tolerability of Dutasteride 0.5 mg Once Daily in Male Patients with Male Pattern Hair Loss: A Randomized, Double-Blind, Placebo-Controlled, Phase III Study Journal of The American Academy of Dermatology · 2010
    6. Prevalence and Types of Androgenetic Alopecia in Shanghai, China: A Community-Based Study British Journal of Dermatology · 2009
    7. Male Pattern Baldness: Current Treatments, Future Prospects Drug Discovery Today · 2008
    8. Association of Androgenetic Alopecia With Smoking and Its Prevalence Among Asian Men Archives of Dermatology · 2007
    9. The Importance of Dual 5α-Reductase Inhibition in the Treatment of Male Pattern Hair Loss: Results of a Randomized Placebo-Controlled Study of Dutasteride Versus Finasteride Journal of The American Academy of Dermatology · 2006
    10. The Prevalence and Types of Androgenetic Alopecia in Korean Men and Women British Journal of Dermatology · 2001
    11. Male-Pattern Hair Loss in Norwegian Men: A Community-Based Study Dermatology · 2000
    12. The Effects of Finasteride on Scalp Skin and Serum Androgen Levels in Men with Androgenetic Alopecia Journal of The American Academy of Dermatology · 1999
    13. Finasteride in the Treatment of Men with Androgenetic Alopecia Journal of The American Academy of Dermatology · 1998

    Related research 2

    1. Long-Term Safety and Efficacy of Dutasteride in the Treatment of Male Patients with Androgenetic Alopecia Journal of Dermatology · 2016
    2. Adverse Side Effects of 5α-Reductase Inhibitors Therapy: Persistent Diminished Libido, Erectile Dysfunction, and Depression in a Subset of Patients The Journal of Sexual Medicine · 2010